Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Nanobiotechnology approaches for cardiovascular diseases: site-specific targeting of drugs and nanoparticles for atherothrombosis

Abstract Atherosclerosis and atherothrombosis, the major contributors to cardiovascular diseases (CVDs), represent the leading cause of death worldwide. Current pharmacological therapies have been associated with side effects or are insufficient at halting atherosclerotic progression effectively. Pi...

Full description

Bibliographic Details
Main Authors: Haikun Liu, Geoffrey Pietersz, Karlheinz Peter, Xiaowei Wang
Format: Article
Language:English
Published: BMC 2022-02-01
Series:Journal of Nanobiotechnology
Subjects:
Antibodies
Atherosclerosis
Gene delivery
Nanoparticles
Targeted drug delivery
Thrombosis
Online Access:https://doi.org/10.1186/s12951-022-01279-y

Internet

https://doi.org/10.1186/s12951-022-01279-y

Similar Items